Filing Details
- Accession Number:
- 0001048477-24-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-12 15:07:42
- Reporting Period:
- 2024-04-10
- Accepted Time:
- 2024-04-12 15:07:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1927648 | Erin Burkhart | C/O Biomarin Pharmaceutical Inc. 770 Lindaro Streeet San Rafael CA 94901 | Gvp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-04-10 | 2,286 | $90.00 | 16,156 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on November 29, 2023.
Billionaire Hedge Funds
